Attractions for Japanese companies in the Global Artificial Intelligence in Healthcare Market
As rightly pointed by analysts that Artificial intelligence (AI) in healthcare is the use of algorithms and software to approximate human cognition in the analysis of complex medical data. With the advancement of technology markets such as USA, China, Korea, Japan, Australia, EU5 are increasingly investing in AI. With the convergence of big data in healthcare, artificial intelligence looks like the inevitable future for mankind.
Currently the market is less than 1 Billion USD but it appears that soon the market would cross 8 Billion by 2025. Patient data, risk analytics, drug discovery, medical imaging and lifestyle management shall grow high in the next 5-7 years. North America and APAC shall compete for market share closely followed by Europe.
With heavy investments in AI, the market is one of the most sought after segments where Several ICT companies have switched as Healthcare providers. This is a must read for Tech companies based out of China, Japan and South Korea in 2019.
Currently the market is less than 1 Billion USD but it appears that soon the market would cross 8 Billion by 2025. Patient data, risk analytics, drug discovery, medical imaging and lifestyle management shall grow high in the next 5-7 years. North America and APAC shall compete for market share closely followed by Europe.
With heavy investments in AI, the market is one of the most sought after segments where Several ICT companies have switched as Healthcare providers. This is a must read for Tech companies based out of China, Japan and South Korea in 2019.
1. ASSUMPTIONS FOR PRIMARY/SECONDARY RESEARCH
2. CURRENCY EXCHANGE RATES
3. ABBREVIATIONS
4. INTRODUCTION – AI IN HEALTHCARE MARKET
a. Recent Trends
b. Demand for AI
c. Top 5 Markets using AI
d. Demand and Supply Gaps
5. DRIVERS AND RESTRAINTS
6. SWOT ANALYSIS
7. REGULATIONS IN THE AI HEALTHCARE MARKET
8. SEGMENTATION OF THE AI IN HEALTHCARE MARKET
a. By Offerings (Hardware, Network, Software)
b. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
c. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
d. By Geography (North America, Europe, APAC and ROW)
e. By Competition
9. NORTH AMERICAN AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (US and Canada)
v. By Competition
e. Key Recommendations
10. EUROPEAN AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (Germany, France & UK)
v. By Competition
e. Key Recommendations
11. APAC AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (China, Japan & Australia)
v. By Competition
e. Key Recommendations
12. THE FINAL WORD
13. APPENDIX
2. CURRENCY EXCHANGE RATES
3. ABBREVIATIONS
4. INTRODUCTION – AI IN HEALTHCARE MARKET
a. Recent Trends
b. Demand for AI
c. Top 5 Markets using AI
d. Demand and Supply Gaps
5. DRIVERS AND RESTRAINTS
6. SWOT ANALYSIS
7. REGULATIONS IN THE AI HEALTHCARE MARKET
8. SEGMENTATION OF THE AI IN HEALTHCARE MARKET
a. By Offerings (Hardware, Network, Software)
b. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
c. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
d. By Geography (North America, Europe, APAC and ROW)
e. By Competition
9. NORTH AMERICAN AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (US and Canada)
v. By Competition
e. Key Recommendations
10. EUROPEAN AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (Germany, France & UK)
v. By Competition
e. Key Recommendations
11. APAC AI IN HEALTHCARE MARKET
a. Regulations in the Market
b. Competition in the Market
c. Recent launches
d. Segmentation of the Market
i. By Offerings (Hardware, Network, Software)
ii. By Technology (Machine Learning, Natural Learning, Context Aware Computing, Others)
iii. By Application Areas (Hospitals, Drug Trials, R&D/Innovation Centres, etc)
iv. By Geography (China, Japan & Australia)
v. By Competition
e. Key Recommendations
12. THE FINAL WORD
13. APPENDIX
